Avalo Therapeutics, Inc. (AVTX)
13.19
+0.33
(+2.57%)
USD |
NASDAQ |
Apr 29, 12:13
Avalo Therapeutics Price : 13.19 for April 29, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Catalyst Pharmaceuticals, Inc. | 28.26 |
| AbbVie, Inc. | 203.77 |
| Relmada Therapeutics, Inc. | 7.28 |
| Theravance Biopharma, Inc. | 16.71 |
| Corcept Therapeutics, Inc. | 47.05 |
Price Related Metrics
| PS Ratio | 3010.11 |
| Price to Book Value | 3.619 |
| Earnings Yield | -46.22% |
| Market Cap | 300.58M |